A novel fluorescence probe for rapid in vitro diagnosis of hypercholesterolemia serum

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200062879

Enrollment

Unknown

Registered

2022-08-22

Start date

2022-08-22

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HLP (hyperlipidaemia)

Interventions

Gold Standard:Patients with hypercholesterolemia were diagnosed according to the 2016 Guidelines for the prevention and treatment of dyslipidemia in Adults in China. Total serum cholesterol TC >= 5.18

Index test:The&#32

fluorescence&#32

intensity&#32

of&#32

the&#32

mixture&#32

serum&#32

and&#32

molecule.

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with hypercholesterolemia were diagnosed according to the 2016 Guidelines for the prevention and treatment of dyslipidemia in Adults in China. Total serum cholesterol TC >= 5.18 mmol/L.

Exclusion criteria

Exclusion criteria: No specific exclusion criteria.

Design outcomes

Primary

Measure	Time frame
Total cholesterol;	—

Countries

China

Contacts

Public ContactZhang Hongfei

Zhujiang Hospital, Southern Medical Univiersity

hongfeiz2003@163.com+86 15625059521

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026